Headlands Technologies’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Headlands Technologies’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,038	Closed	-$32.1K	–	1707
2024 Q1	$32.1K	Buy	+2,038	New	+$31.4K	0.01%	813

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Headlands Technologies's DCPH Position: Q2 2024 in Review

Headlands Technologies sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 2,038 shares — an estimated $32.1K sold.

Headlands Technologies first reported a position in DCPH in Q1 2024 and held it in 1 quarter. The position peaked at $32.1K in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Headlands Technologies reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Headlands Technologies sold 2,038 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $32.1K.
Headlands Technologies first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Headlands Technologies's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $32.1K in Q1 2024.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Headlands Technologies's 13F filing for Q2 2024, filed 7 Aug 2024.